Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 14Unknown 5Active not recruiting 5Terminated 4Withdrawn 3Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2Other 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Overweight 1Obesity 1Carcinoma, Signet Ring Cell 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Biopsy, Needle × Clear all
NCT04291950 2022-12-20

Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women

University of Arizona

Withdrawn
BreastOther

Breast Neoplasms, Obesity, Overweight, Triple Negative Breast Neoplasms

NCT02594943 2018-11-26

Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer

Region Skane

Phase NA Withdrawn
Gastrointestinal

Stomach Neoplasms, Carcinoma, Signet Ring Cell

NCT00903214 2013-04-29

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡